Whittier Trust Co. of Nevada Inc. Increases Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Whittier Trust Co. of Nevada Inc. boosted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 7.5% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 41,874 shares of the exchange traded fund’s stock after purchasing an additional 2,904 shares during the period. Whittier Trust Co. of Nevada Inc. owned about 0.09% of SPDR S&P Biotech ETF worth $3,673,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. JPMorgan Chase & Co. lifted its position in shares of SPDR S&P Biotech ETF by 56.6% during the 1st quarter. JPMorgan Chase & Co. now owns 4,761,913 shares of the exchange traded fund’s stock valued at $431,143,000 after buying an additional 1,720,255 shares in the last quarter. Q3 Asset Management purchased a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at about $3,285,000. Clal Insurance Enterprises Holdings Ltd lifted its position in shares of SPDR S&P Biotech ETF by 55.5% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 933,000 shares of the exchange traded fund’s stock valued at $84,474,000 after buying an additional 333,000 shares in the last quarter. Janney Capital Management LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 1st quarter valued at about $14,297,000. Finally, American Century Companies Inc. purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at about $9,069,000.

Shares of XBI stock traded down $2.20 during trading hours on Friday, reaching $83.71. 258,604 shares of the company traded hands, compared to its average volume of 4,699,137. SPDR S&P Biotech ETF has a 12-month low of $64.38 and a 12-month high of $100.70. The stock’s 50-day moving average price is $85.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Story: Moving Average (MA)

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.